{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981471216897152.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1097/fpc.0000000000000124"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/10.1097/FPC.0000000000000124"}}],"dc:title":[{"@value":"HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity"}],"dcterms:alternative":[{"@value":"a systematic review of the literature and meta-analysis"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381981471216897155","@type":"Researcher","foaf:name":[{"@value":"Elena M. Cornejo Castro"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471216897154","@type":"Researcher","foaf:name":[{"@value":"Daniel F. Carr"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471216897153","@type":"Researcher","foaf:name":[{"@value":"Andrea L. Jorgensen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471216897152","@type":"Researcher","foaf:name":[{"@value":"Ana Alfirevic"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981471216897156","@type":"Researcher","foaf:name":[{"@value":"Munir Pirmohamed"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"17446872"}],"prism:publicationName":[{"@value":"Pharmacogenetics and Genomics"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2015-04","prism:volume":"25","prism:number":"4","prism:startingPage":"186","prism:endingPage":"198"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/10.1097/FPC.0000000000000124"}],"createdAt":"2015-02-14","modifiedAt":"2021-05-14","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360846639456371200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Medication Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204632268800","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand"},{"@language":"en","@value":"Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1097/fpc.0000000000000124"},{"@type":"CROSSREF","@value":"10.1016/j.alit.2016.04.001_references_DOI_TwKl4m1bz3WQmm3mEb8gqoBY2wt"},{"@type":"CROSSREF","@value":"10.1002/cpt.1071_references_DOI_TwKl4m1bz3WQmm3mEb8gqoBY2wt"}]}